LS Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,810
| Closed | -$43K | – | 1372 |
|
|
2020
Q2 | $43K | Hold |
1,810
| – | – | ﹤0.01% | 1215 |
|
|
2020
Q1 | $33K | Hold |
1,810
| – | – | ﹤0.01% | 1221 |
|
|
2019
Q4 | $43K | Sell |
1,810
-4,237
| -70% | -$101K | ﹤0.01% | 1353 |
|
|
2019
Q3 | $166K | Hold |
6,047
| – | – | 0.01% | 853 |
|
|
2019
Q2 | $200K | Buy |
6,047
+71
| +1% | +$2.35K | 0.01% | 780 |
|
|
2019
Q1 | $209K | Buy |
5,976
+543
| +10% | +$19K | 0.01% | 772 |
|
|
2018
Q4 | $180K | Sell |
5,433
-492
| -8% | -$16.3K | 0.01% | 783 |
|
|
2018
Q3 | $298K | Sell |
5,925
-1,059
| -15% | -$53.3K | 0.02% | 690 |
|
|
2018
Q2 | $418K | Sell |
6,984
-30
| -0.4% | -$1.8K | 0.03% | 575 |
|
|
2018
Q1 | $321K | Sell |
7,014
-2
| -0% | -$92 | 0.02% | 660 |
|
|
2017
Q4 | $280K | Sell |
7,016
-2,132
| -23% | -$85.1K | 0.02% | 735 |
|
|
2017
Q3 | $366K | Buy |
9,148
+2,162
| +31% | +$86.5K | 0.02% | 669 |
|
|
2017
Q2 | $301K | Sell |
6,986
-68
| -1% | -$2.93K | 0.02% | 740 |
|
|
2017
Q1 | $221K | Buy |
7,054
+4,943
| +234% | +$155K | 0.01% | 805 |
|
|
2016
Q4 | $53K | Hold |
2,111
| – | – | ﹤0.01% | 1236 |
|
|
2016
Q3 | $52K | Buy |
2,111
+677
| +47% | +$16.7K | ﹤0.01% | 1203 |
|
|
2016
Q2 | $29K | Buy |
1,434
+234
| +20% | +$4.73K | ﹤0.01% | 1397 |
|
|
2016
Q1 | $18K | Hold |
1,200
| – | – | ﹤0.01% | 1512 |
|
|
2015
Q4 | $16K | Hold |
1,200
| – | – | ﹤0.01% | 1552 |
|
|
2015
Q3 | $17K | Buy |
1,200
+114
| +10% | +$1.62K | ﹤0.01% | 1524 |
|
|
2015
Q2 | $18K | Buy |
+1,086
| New | +$18K | ﹤0.01% | 1540 |
|